Kenya drug regulator recalls a batch of JnJ children cough syrup
Nairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following Nigeria's recall of the same batch of medication under the Benylin Paediatric brand.
Nigeria's health regulator revealed that laboratory tests conducted on the syrup indicated a concerning level of diethylene glycol. This chemical has been associated with the deaths of numerous children in countries including Gambia, Uzbekistan, and Cameroon since 2022, marking one of the most severe episodes of poisoning linked to oral medication worldwide.
According to a Reuters report, the Pharmacy and Poisons Board (PPB) of Kenya stated in a statement that it had initiated investigations into the matter and recommended the suspension of sales for certain batches of the product, urging their return to suppliers.
Kenvue, the entity now in possession of the Benylin brand following its separation from J&J last year, responded by stating its engagement with Nigeria's health regulator and undertaking its own evaluation to authenticate the sampled product, assess testing procedures, and review results.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.